Tagrisso
| Tagrisso | |
|---|---|
| Term | Tagrisso |
| Short definition | Tagrisso - (pronounced) (tuh-GRIH-soh) drug used to treat adults with certain types of non-small cell lung cancer that have certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Tagrisso - (pronounced) (tuh-GRIH-soh) drug used to treat adults with certain types of non-small cell lung cancer that have certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. Tagrisso blocks certain proteins made by the mutated EGFR gene, which can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called osimertinib mesylate
External links
- Medical encyclopedia article on Tagrisso
- Wikipedia's article - Tagrisso
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski